NDC 0310-1830
Fasenra 30 mg per 1 mL injection, solution
On the label: AstraZeneca Pharmaceuticals LP.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| AstraZeneca AB | Sodertalje, Sweden | Makes it | Problems found, fixed voluntarilyDec 12, 2025 · 9 inspections |
Recalls
- Oct 8, 2025 · Class II · Astrazeneca Pharmaceuticals
Lack of Assurance of Sterility:
Lots: Lot YJ0152, Expiry: 01/31/2028.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Benralizumab: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 30 mg per 1 mL
- Approval
- BLA BLA761070
- On the market since
- Oct 4, 2019
- Package NDCs
0310-1830-300310-1830-85- Official label
- DailyMed (National Library of Medicine), updated May 13, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?